000 02879cam a2200517 a 4500
001 u159119
003 SIRSI
005 20240916205751.0
008 110622s2011 maua b 001 0 eng
010 _a 2011026672
015 _aGBB1B5940
_2bnb
020 _a9780674061583
_q(alk. paper)
020 _a0674061586
_q(alk. paper)
020 _a9780674063150
_q(ebook)
020 _a0674063155
_q(ebook)
035 _a(OCoLC)733916545
_z(OCoLC)709670327
_z(OCoLC)756280547
_z(OCoLC)779361993
050 0 0 _aRA638
_b.H69 2011
060 0 0 _a2012 B-936
060 1 0 _aQW 11 AA1
082 0 0 _a614.4/7
_223
092 _a614.47
_bH869L
100 1 _aHoyt, Kendall,
_d1971-
245 1 0 _aLong shot :
_bvaccines for national defense /
_cKendall Hoyt.
260 _aCambridge, Mass. :
_bHarvard University Press,
_c2011.
300 _axi, 300 pages :
_billustrations ;
_c25 cm
336 _atext
_btxt
_2rdacontent
337 _aunmediated
_bn
_2rdamedia
338 _avolume
_bnc
_2rdacarrier
504 _aIncludes bibliographical references and index.
505 0 _aDisease, security, and vaccines -- Historical patterns of vaccine innovation -- Vaccine development during World War II -- Wartime legacies -- The end of an era -- Biodefense in the 21st century -- The search for sustainable solutions.
520 _aHistorically, the US has excelled at responding to national health emergencies and developing new or improved vaccines, often in time to meet the objectives of particular military missions. However, probing vaccine development for factors that foster timely innovation found it has been falling, not rising since WWII. Ironically, the biotechnology industry boom and the rise of specialization and outsourcing has undercut the collaborative networks and research practices that drove successful vaccine projects in the past. The author's investigation teaches important lessons for our efforts to rebuild 21st century biodefense capabilities, especially when the financial payback for a particular vaccine is low, but the social returns are high.
650 0 _aVaccination
_zUnited States.
650 0 _aVaccines
_xGovernment policy
_zUnited States.
650 0 _aBiological weapons
_xSafety measures
_xGovernment policy
_zUnited States.
650 1 2 _aVaccines
_xhistory.
650 1 2 _aHistory, 20th Century.
650 2 2 _aSecurity Measures.
650 2 2 _aBiological Warfare Agents.
651 2 _aUnited States.
650 7 _aVaccination.
_2fast
_0(OCoLC)fst01163544
650 7 _aVaccines
_xGovernment policy.
_2fast
_0(OCoLC)fst01163579
651 7 _aUnited States.
_2fast
_0(OCoLC)fst01204155
776 1 _cElectronic resource
_z9780674063150
856 4 1 _uhttps://doi.org/10.4159/harvard.9780674063150
949 _cc.1
_lON-ORDER
_tBOOK
_xPRINT
_p
999 _a614.47 H869L
_wDEWEY
_c5766
_i51994001659558
_f7/3/2023
_g2
_lCIRCSTACKS
_mLRC
_p$29.95
_rY
_sY
_tBOOK
_u10/22/2019
_xPRINT
_d5766